Kindeva Drug Delivery

Kindeva Drug Delivery Expands Loughborough, UK, Facilities at Charnwood Campus to Support Growth of Green Propellant Commercialisation

4 June 2024 -- Loughborough, UK; Minnesota, US; and Missouri, US -- Leading global drug-device combination product CDMO Kindeva Drug Delivery today announced the expansion of their Loughborough, UK, facilities at the Charnwood Campus Science Innovation and Technology Park. This strategic move by Kindeva supports the growth of green propellant commercialisation and secures a dedicated...

Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site

6 May 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurised metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, UK, facility. This new line will be capable of...

Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services

18 March 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today welcomes Jennifer Riter as vice president of Analytical Services to head up the recently announced analytical services global business unit. Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in...

Kindeva Drug Delivery Launches New Analytical Services Global Business Unit

31 January 2024 -- Minnesota, US and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, announced the expansion of its analytical services capabilities — launching a new global business unit offering integrated and stand-alone analytical support to the wider pharmaceutical, biopharmaceutical and medical device sector. For more than half a...